Identification of Potential Molecular Targets and Active Ingredients of Mingmu Dihuang Pill for the Treatment of Diabetic Retinopathy Based on Network Pharmacology

Table 4

Molecular docking of active ingredients of Mingmu Dihuang pill with key targets for diabetic retinopathy.

Target	Active ingredient	Docking energy (kcal/mol)
AKT1	Luteolin	–9.7
AKT1	Acacetin	–9.4
AKT1	Alisol B	–7.9
AKT1	Naringenin	–8.0
SRC	Luteolin	–8.4
SRC	Acacetin	–8.4
SRC	Alisol B	–9.0
SRC	Naringenin	–7.6
VEGFA	Luteolin	–8.1
VEGFA	Acacetin	–7.6
VEGFA	Alisol B	–8.3
VEGFA	Naringenin	–6.9